FDA drug approval affects health care around the world, but political shortcuts could hurt the agency's reputation

3 months ago 11
At the opening of July 2026, the U.S. Food and Drug Administration approved the archetypal cistron therapy for young children with sickle compartment disease.
Read Entire Article